Drug Profile
Ilepatril
Alternative Names: AVE 7688Latest Information Update: 11 Aug 2008
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Class 3-ring heterocyclic compounds; Antihypertensives; Heart failure therapies; Small molecules
- Mechanism of Action ACE inhibitors; Neprilysin inhibitors; Vasopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic nephropathies; Heart failure; Hypertension
Most Recent Events
- 31 Jul 2008 Discontinued - Phase-I for Congestive heart failure in France (PO)
- 31 Jul 2008 Discontinued - Phase-II for Diabetic nephropathies in France (PO)
- 31 Jul 2008 Discontinued - Phase-II for Hypertension in France (PO)